GeneNews launches ColonSentry in Malaysia

GeneNews (TSX:GEN) has announced the commercial launch of ColonSentry, the world’s first blood-based test to determine a person’s current risk for colorectal cancer, in Malaysia through its GeneNews Diagnostics Sdn. Bhd. subsidiary. “We are excited that GeneNews Diagnostics will now be able to provide the Malaysian population with access to this potentially life-saving colorectal cancer [...]

Malaysian study further validates GeneNews’ ColonSentry

A 210-patient Malaysian study entitled “Blood-based Seven-gene Biomarker Panel for Colorectal Cancer: Validation in Malaysia” has been presented at the 2010 National Committee for Clinical Research conference in Kuala Lumpur. GeneNews (TSX:GEN) said the seven-gene biomarker panel forms the basis of its lead ColonSentry product, the world’s first blood test for colorectal cancer.  The abstract [...]